Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

FDA Proposes to Know More About Antibiotic Use in Animals

May 21, 2015 9:51 am | by Mary Clare Jalonick, Associated Press | News | Comments

The Food and Drug Administration is moving to collect more information on antibiotics used in animals that become meat. It's an effort to stem antibiotic-resistant diseases. Read more...

TOPICS:

Researchers Discover a Treatment to Block MS Progression

May 21, 2015 9:46 am | by University of Montreal | News | Comments

There is no effective cure for MS. Read more...

Chemo Before Surgery Benefits Patients with Advanced Ovarian Cancer

May 21, 2015 9:39 am | by Cancer Research UK | News | Comments

550 women with the disease took part in the trial, with 276 given the standard treatment of surgery followed by six cycles of chemotherapy, and 274 had surgery after three cycles of chemotherapy. Read more...

TOPICS:
Advertisement

Actavis Launches New Alzheimer's Disease Therapy

May 21, 2015 9:30 am | News | Comments

The drug was approved by the U.S. Food and Drug Administration (FDA) in December for the treatment of moderate to severe Alzheimer's disease in patients stabilized on memantine hydrochloride and donepezil hydrochloride. Read more...

TOPICS:

Brain Plaque Forecasts Alzheimer’s Years in Advance, Studies Confirm

May 20, 2015 1:49 pm | by Stephanie Guzowski, Editor | News | Comments

Brain plaques may appear up to 30 years prior to developing Alzheimer’s disease, according to the largest analysis to date of beta amyloid in people’s brains. Findings from two new meta-analyses  also confirm that amyloid screening, by PET scan or cerebral spinal fluid test, can help identify the best participants for clinical trials of Alzheimer’s drugs. Read more...

TOPICS:

Lakewood-Amedex: Novel Class Of Antimicrobials Kills Multidrug Resistant-Tuberculosis

May 20, 2015 12:51 pm | News | Comments

Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today that a recent series of in vitro studies conducted by Southern Research in Birmingham, Alabama, have demonstrated that its novel class of antimicrobials, named bisphosphocins, have proven effective at killing multidrug-resistant (MDR) strains.  Read more...

TOPICS:

FDA Approves First and Only Four-Times-A-Year Schizophrenia Treatment

May 20, 2015 12:44 pm | News | Comments

There's a new treatment option for schizophrenia – Invega Trinza (three-month paliperidone palmitate), the first and only schizophrenia medication to be administered just four times a year, providing the longest dosing interval available. Read more...

TOPICS:

Johnson & Johnson Expects Lucrative Return on Drug Pipeline

May 20, 2015 12:35 pm | by Associated Press | News | Comments

Johnson & Johnson expects a lucrative return from its pharmaceutical business, with plans to seek approval by 2019 for more than 10 new products, each with the potential to top $1 billion in annual sales. Read more...

TOPICS:
Advertisement

Activists Want to Void Patents on Gilead's High-Priced Hepatitis C Drug

May 20, 2015 12:15 pm | by Ryan Bushey, Associate Editor | Articles | Comments

These patents are being challenged all over the world. Read more...

TOPICS:

Promising Malaria and Dengue Vaccines Will Not Defeat Diseases

May 20, 2015 8:54 am | by Christopher J. Pace, Ph.D., GlobalData Managing Analyst, Infectious Diseases | Articles | Comments

Some industry pundits rightfully question the modest protective efficacies of CYD-TDV and RTS,S/AS01. Read more...

TOPICS:

Cancer Drugs Approved Quickly but Not to Patient's Benefit

May 20, 2015 8:46 am | by York University | News | Comments

High priced cancer drugs get rushed approvals despite poor trial methodology and little effect on the longevity of patients. Read more...

TOPICS:

Sanofi, Regeneron Announce Positive Phase 2 Data for Asthma Drug

May 20, 2015 8:42 am | News | Comments

Based on discussions with the U.S. Food and Drug Administration (FDA), this Phase 2b study may be considered one of two pivotal efficacy studies required for a potential dupilumab biologics license application (BLA) in asthma. Read more...  

TOPICS:

HIV Reservoirs Remain Obstacles to Cure

May 20, 2015 8:41 am | by NIAID | News | Comments

A primary research goal is to find an HIV cure that either clears the virus from an infected person’s body or enables HIV-infected individuals to suppress virus levels and replication to extremely low levels without the need for daily ART. Read more...

TOPICS:

Australian Researcher Helps with Ebola Vaccine Trials

May 20, 2015 8:41 am | by Monash University | News | Comments

An Australian researcher has helped identify the kind of human trial that is most effective for testing Ebola vaccines. Read more...

TOPICS:

New Alzheimer's Drug to Enter Clinical Trials

May 20, 2015 8:39 am | by Lancaster University | News | Comments

A new drug developed at Lancaster University that may help to prevent the early stages of Alzheimer’s disease is to enter clinical trials. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading